Oppenheimer raises Biogen price target on growing investor confidence By Investing.com – Canada Boosts
© Reuters Oppenheimer raises Biogen value goal on rising investor confidence Oppenheimer raised the value goal on Biogen (NASDAQ:) to $295.00 from $280.00 whereas sustaining an Outperform score. Analysts highlighted rising investor confidence in Biogen administration with optimistic suggestions on the CEO and CFO, based mostly on the outcomes of a 2,000+ investor survey by…